Correlation Between Soleno Therapeutics and NeuBase Therapeutics

Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and NeuBase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and NeuBase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Soleno Therapeutics and NeuBase Therapeutics, you can compare the effects of market volatilities on Soleno Therapeutics and NeuBase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of NeuBase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and NeuBase Therapeutics.

Diversification Opportunities for Soleno Therapeutics and NeuBase Therapeutics

-0.56

Correlation Coefficient

Soleno Therapeutics  NeuBase Therapeutics

Excellent diversification

The 3 months correlation between Soleno and NeuBase is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and NeuBase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuBase Therapeutics and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with NeuBase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuBase Therapeutics has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and NeuBase Therapeutics go up and down completely randomly.

Pair Corralation between Soleno Therapeutics and NeuBase Therapeutics

If you would invest  4,727  in Soleno Therapeutics on September 3, 2024 and sell it today you would earn a total of  544.00  from holding Soleno Therapeutics or generate 11.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	1.56%
Values	Daily Returns

Soleno Therapeutics  vs.  NeuBase Therapeutics

Soleno Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Soleno Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

NeuBase Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NeuBase Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, NeuBase Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Soleno Therapeutics and NeuBase Therapeutics

The main advantage of trading using opposite Soleno Therapeutics and NeuBase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, NeuBase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuBase Therapeutics will offset losses from the drop in NeuBase Therapeutics' long position.

The idea behind Soleno Therapeutics and NeuBase Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.